|
End-of-day quote
Santiago S.E.
|
||
| - CLP | - |
|
| 17/05/14 | Abbott Laboratories : to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| 16/05/14 | AbbVie : Abbott to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.24% | +4.88% | +68.46% | +142.26% | 1,148B | ||
| +1.30% | +2.57% | +47.10% | +86.69% | 652B | ||
| +0.80% | +1.26% | +28.27% | +103.53% | 505B | ||
| +0.73% | +2.45% | +54.26% | +66.47% | 384B | ||
| +4.86% | +0.80% | +71.43% | +44.55% | 348B | ||
| +2.38% | +2.65% | +34.31% | +56.33% | 294B | ||
| +2.26% | +0.55% | +3.92% | +27.74% | 264B | ||
| +1.36% | +2.56% | +57.23% | +74.30% | 244B | ||
| +1.11% | +2.49% | +35.96% | +107.16% | 197B | ||
| Average | +2.40% | +1.39% | +44.55% | +78.78% | 448.57B | |
| Weighted average by Cap. | +3.09% | +1.50% | +49.91% | +93.24% |
- Stock Market
- Stocks
- CFR Stock
Select your edition
All financial news and data tailored to specific country editions
















